Sweden Herald
AstraZeneca denies merger talks with
Photo: Fredrik Sandberg/TT
Business

AstraZeneca denies merger talks with Bristol Myers Squibb

Pharmaceutical giant AstraZeneca is not in talks over a deal with rival Bristol Myers Squibb, according to information provided to Reuters. Earlier this week, the Financial Times reported that the pharmaceutical giants were discussing a merger.

"There is no deal between Astra Zeneca and Bristol Myers Squibb. There was never any deal to be made, and there are no discussions between the companies," the source told Reuters.

On Monday, Astra Zeneca plunged 9.4 percent on the Stockholm Stock Exchange after the Financial Times published information about a possible merger between the companies.

Today, the stock is recovering slightly, according to Reuters data. At 3:10 p.m., the stock was up almost 3 percent on the Stockholm Stock Exchange.

In this story
Financial TimesBristol Myers Squibb
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers

What do you think?

Keep readingmore from Business

All